578 Tumor selective immune responses of STA551, a novel anti-CD137 agonist antibody activated by extracellular ATP

578 Tumor selective immune responses of STA551, a novel anti-CD137 agonist antibody activated by extracellular ATP

Bibliographic Details
Main Authors:	Yoshinori Narita, Mika Kamata-Sakurai
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist
by: Sailaja Battula, et al.
Published: (2021-01-01)

An Agonistic Anti-CD137 Antibody Disrupts Lymphoid Follicle Structure and T-Cell-Dependent Antibody Responses
by: Jun P. Hong, et al.
Published: (2020-06-01)

Modulation of NK Cell Function with Agonistic α-CD137 Antibodies During MCMV Infection
by: Hahm, Dahn
Published: (2017)

Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137
by: Li SY, et al.
Published: (2013-09-01)

S100A4 blockage alleviates agonistic anti-CD137 antibody-induced liver pathology without disruption of antitumor immunity
by: Jinhua Zhang, et al.
Published: (2018-04-01)

377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects
by: Nicholas Wilson, et al.
Published: (2020-11-01)

814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
by: Mark Throsby, et al.
Published: (2020-11-01)

An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer
by: Dinh-Toi Chu, et al.
Published: (2019-04-01)

647 Evaluation of efficacy and toxicity of CD137 immunotherapy with urelumab-mIgG1 chimeric antibody in CD137 HuGEMM™
by: Daniel He, et al.
Published: (2020-11-01)

Agonistic CD40 Antibodies in Cancer Treatment
by: Dijana Djureinovic, et al.
Published: (2021-03-01)

The role of CD40 and CD137 in immune responses to cancer : a study of monoclonal antibody mediated immunomodulation in two murine tumour models
by: Green, Michael
Published: (2003)

The yin and yang functions of extracellular ATP and adenosine in tumor immunity
by: Li-li Feng, et al.
Published: (2020-04-01)

Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells
by: Sakthi Rajendran, et al.
Published: (2019-09-01)

700 EphA2/CD137 Bicycle tumor-targeted immune cell agonists (TICAsTM) induce tumor regressions, immunogenic memory, and reprogramming of the tumor immune microenvironment
by: Jun Ma, et al.
Published: (2020-11-01)

Ionizing Radiation Effects on Hs 578Bst Microtubules
by: L. Bruni, et al.
Published: (2020-11-01)

CD137L-DCs, Potent Immune-Stimulators—History, Characteristics, and Perspectives
by: Qun Zeng, et al.
Published: (2019-10-01)

CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8+ T cells via NF-κB signaling
by: Ben-Shun Hu, et al.
Published: (2020-10-01)

Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis
by: Khang Luu, et al.
Published: (2021-02-01)

The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity
by: Beom K. Choi, et al.
Published: (2020-12-01)

Dissection of agonistic and blocking effects of CD200 receptor antibodies.
by: Munir Akkaya, et al.
Published: (2013-01-01)

The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus
by: Anselm Mak, et al.
Published: (2019-09-01)

Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17.
by: Christopher Paustian, et al.
Published: (2013-01-01)

6-Hydroxy-5,7,8-trimethylchroman-2-one
by: Shailesh K. Goswami, et al.
Published: (2011-07-01)

CD137-CD137L interaction regulates atherosclerosis via cyclophilin A in apolipoprotein E-deficient mice.
by: Yuefeng Li, et al.
Published: (2014-01-01)

Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy
by: Daniel Baumann, et al.
Published: (2020-08-01)

Extracellular ATP Regulates CD73 and ABCC6 Expression in HepG2 Cells
by: Fabio Martinelli, et al.
Published: (2018-08-01)

The Earthquake of A.D. 551 and the Birth-date of Agathias
by: Ronald C. McCail
Published: (2003-03-01)

Xiao Gang (503-551) : his life and literature
by: Deng, Qingzhen
Published: (2013)

Plautus' Amphitruo : a commentary on lines 551-860
by: Frost, Kathryn Jane
Published: (1989)

Xiao Gang (503-551) : his life and literature
by: Deng, Qingzhen
Published: (2013)

The Conducting and Interpretation of Mozart's "Jupiter-Symphony" k.551
by: Chang Yung-Shun, et al.
Published: (2002)

Xiao Gang (503-551) : his life and literature
by: Deng, Qingzhen
Published: (2013)

The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies.
by: Zofia Pilch, et al.
Published: (2019-01-01)

ROLE OF AUTOPHAGY IN THE RESPONSE OF HS578T BREAST TUMOR CELLS TO RADIATION
by: Chakradeo, Shweta
Published: (2012)

Polifemo, Sileno e le Cariti (Eur. Cycl. 578-584)
by: Lenoardo Paganelli
Published: (1981-06-01)

A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade
by: Cecile Geuijen, et al.
Published: (2021-07-01)

Em Sta.Catarina
by: CCFEx REF/JPE
Published: (2020-02-01)

ŠTA JE DOPING?
by: Nenad Mačvanin, et al.
Published: (2011-03-01)

Identification of CD137-Expressing B Cells in Multiple Sclerosis Which Secrete IL-6 Upon Engagement by CD137 Ligand
by: Hiu Yi Wong, et al.
Published: (2020-11-01)

CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches
by: Maria A. Argiriadi, et al.
Published: (2019-08-01)

Cannot write session to /tmp/vufind_sessions/sess_faf34c2n6m7a28v6hd4k0cvr6d